Why the study?
Despite improved survival with guideline-directed medical therapy, impairments in quality of life and functional capacity persist in ambulatory heart failure patients who often value quality of life over extended survival.
May inform risk discussions after HF clinic or ED visits but should not yet change practice; leaves open QoL-targeted intervention trials.
Overall survival rates for ambulatory patients with heart failure (HF) have improved with the uptake of guideline-directed medical therapy, but impairments in quality of life (QoL) and functional capacity persist.1 Patients hospitalized due to HF often experience severe and prolonged declines in QoL, with symptom burdens comparable to those seen in debilitating conditions, such as acute myocardial infarction, end-stage kidney disease, and common malignancies.2,3 Furthermore, prior studies suggest that patients with HF often value improvements in QoL over extended survival.
No takes yet. Share an insight, caveat, or question.
Ambrosy et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: